Literature DB >> 11006262

Effects of hypoxemia on the a- and b-waves of the electroretinogram in the cat retina.

J Kang Derwent1, R A Linsenmeier.   

Abstract

PURPOSE: Slow components of the electroretinogram (ERG) are sensitive to even mild hypoxemia (60 < P(a)O(2) < 100 mm Hg) in the cat eye. However, the electrical responses of the inner retina remain unchanged until P(a)O(2) is below 40 mm Hg. In this study, the effects of hypoxemia on photoreceptors, on which both slow ERG components and inner retinal activity depend, were examined by recording the a-wave of the ERG.
METHODS: The ERG of dark-adapted, anesthetized cats was recorded between an Ag-AgCl electrode in the vitreous humor and a reference electrode near the eye. Responses to bright flashes of diffuse white light were recorded at 3-minute intervals during hypoxemic episodes lasting 15 minutes to 2 hours.
RESULTS: The cat a-wave was well described by the Lamb and Pugh a-wave model during normoxia and hypoxemia. During mild hypoxemia (P(a)O(2) of 50-60 mm Hg), small changes in a-wave amplitude were detected but did not become greater during severe hypoxemia. The mean decrease in the a-wave amplitude during severe hypoxemia (P(a)O(2) of 20-30 mm Hg) was 8.9% from the mean amplitude during air breathing. The effects of hypoxemia were more severe on the b-wave amplitude. The mean decrease in the b-wave was 35% at P(a)O(2) of 20-30 mm Hg.
CONCLUSIONS: The a-wave is more resistant to severe hypoxemia than the b-wave. This implies that photoreceptor transduction works almost normally during hypoxemia and that failure of inner retinal PO(2) regulation causes the decrease in the b-wave. Previously observed changes in the amplitudes of slow ERG components during hypoxemia may result from changes in the ionic environment, rather than a failure of photoreceptor energy metabolism.

Entities:  

Mesh:

Year:  2000        PMID: 11006262

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Probing Metabolism in the Intact Retina Using Stable Isotope Tracers.

Authors:  Jianhai Du; Jonathan D Linton; James B Hurley
Journal:  Methods Enzymol       Date:  2015-06-14       Impact factor: 1.600

2.  Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG.

Authors:  Márta Janáky; Andor Grósz; Erika Tóth; Krisztina Benedek; György Benedek
Journal:  Doc Ophthalmol       Date:  2007-01-09       Impact factor: 2.379

3.  Response of inner retinal oxygen extraction fraction to light flicker under normoxia and hypoxia in rat.

Authors:  Pang-yu Teng; Justin Wanek; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

Review 4.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

5.  Hypoxia reduces the effect of photoreceptor bleaching.

Authors:  Yun-Bin Lin; Jorn-Hon Liu; Yin Chang
Journal:  J Physiol Sci       Date:  2012-04-28       Impact factor: 2.781

6.  The effect of physical effort on retinal activity in the human eye: rod and cone flicker electroretinogram studies.

Authors:  Teresa Zwierko; Damian Czepita; Wojciech Lubiński
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-05       Impact factor: 3.117

Review 7.  Retinal abnormalities in β-thalassemia major.

Authors:  Devang L Bhoiwala; Joshua L Dunaief
Journal:  Surv Ophthalmol       Date:  2015-08-29       Impact factor: 6.048

8.  Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure.

Authors:  Mitchell G Brigell; Bryce Chiang; April Yauguang Maa; C Quentin Davis
Journal:  Transl Vis Sci Technol       Date:  2020-08-26       Impact factor: 3.283

9.  Rod phototransduction and light signal transmission during type 2 diabetes.

Authors:  Silke Becker; Lara S Carroll; Frans Vinberg
Journal:  BMJ Open Diabetes Res Care       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.